{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T22:32:08Z","timestamp":1791844328818,"version":"4.3.4"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2012,4,10]],"date-time":"2012-04-10T00:00:00Z","timestamp":1334016000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/2.0"},{"start":{"date-parts":[[2012,4,10]],"date-time":"2012-04-10T00:00:00Z","timestamp":1334016000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neuroinflammation"],"published-print":{"date-parts":[[2012,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Emerging data implicate nicotinamide phosphoribosyl transferase (NAMPT) in the pathogenesis of cancer and inflammation. NAMPT inhibitors have proven beneficial in inflammatory animal models of arthritis and endotoxic shock as well as in autoimmune encephalitis. Given the role of inflammatory responses in spinal cord injury (SCI), the effect of NAMPT inhibitors was examined in this setting.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We investigated the effects of the NAMPT inhibitor FK866 in an experimental compression model of SCI.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Twenty-four hr following induction of SCI, a significant functional deficit accompanied widespread edema, demyelination, neuron loss and a substantial increase in TNF-\u03b1, IL-1\u03b2, PAR, NAMPT, Bax, MPO activity, NF-\u03baB activation, astrogliosis and microglial activation was observed. Meanwhile, the expression of neurotrophins BDNF, GDNF, NT3 and anti-apoptotic Bcl-2 decreased significantly. Treatment with FK866 (10 mg\/kg), the best known and characterized NAMPT inhibitor, at 1 h and 6 h after SCI rescued motor function, preserved perilesional gray and white matter, restored anti-apoptotic and neurotrophic factors, prevented the activation of neutrophils, microglia and astrocytes and inhibited the elevation of NAMPT, PAR, TNF-\u03b1, IL-1\u03b2, Bax expression and NF-\u03baB activity.<\/jats:p><jats:p>We show for the first time that FK866, a specific inhibitor of NAMPT, administered after SCI, is capable of reducing the secondary inflammatory injury and partly reduce permanent damage. We also show that NAMPT protein levels are increased upon SCI in the perilesional area which can be corrected by administration of FK866.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Our findings suggest that the inflammatory component associated to SCI is the primary target of these inhibitors.<\/jats:p><\/jats:sec>","DOI":"10.1186\/1742-2094-9-66","type":"journal-article","created":{"date-parts":[[2012,4,10]],"date-time":"2012-04-10T12:15:09Z","timestamp":1334060109000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":53,"title":["The NAMPT inhibitor FK866 reverts the damage in spinal cord injury"],"prefix":"10.1186","volume":"9","author":[{"given":"Emanuela","family":"Esposito","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Impellizzeri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emanuela","family":"Mazzon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gohar","family":"Fakhfouri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reza","family":"Rahimian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Travelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gian Cesare","family":"Tron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Armando A","family":"Genazzani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvatore","family":"Cuzzocrea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,4,10]]},"reference":[{"issue":"5","key":"554_CR1_554","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/j.cmet.2007.09.003","volume":"6","author":"JR Revollo","year":"2007","unstructured":"Revollo JR, Korner A, Mills KF, Satoh A, Wang T, Garten A, Dasgupta B, Sasaki Y, Wolberger C, Townsend RR, et al.: Nampt\/PBEF\/Visfatin regulates insulin secretion in beta cells as a systemic NAD biosynthetic enzyme. Cell Metab 2007,6(5):363\u2013375.","journal-title":"Cell Metab"},{"issue":"2","key":"554_CR2_554","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1128\/MCB.14.2.1431","volume":"14","author":"B Samal","year":"1994","unstructured":"Samal B, Sun Y, Stearns G, Xie C, Suggs S, McNiece I: Cloning and characterization of the cDNA encoding a novel human pre-B-cell colony-enhancing factor. Mol Cell Biol 1994,14(2):1431\u20131437.","journal-title":"Mol Cell Biol"},{"issue":"3","key":"554_CR3_554","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.tem.2008.10.004","volume":"20","author":"A Garten","year":"2009","unstructured":"Garten A, Petzold S, Korner A, Imai S, Kiess W: Nampt: linking NAD biology, metabolism and cancer. Trends Endocrinol Metab 2009,20(3):130\u2013138.","journal-title":"Trends Endocrinol Metab"},{"issue":"9","key":"554_CR4_554","doi-asserted-by":"publisher","first-page":"2829","DOI":"10.1002\/art.22833","volume":"56","author":"F Brentano","year":"2007","unstructured":"Brentano F, Schorr O, Ospelt C, Stanczyk J, Gay RE, Gay S, Kyburz D: Pre-B cell colony-enhancing factor\/visfatin, a new marker of inflammation in rheumatoid arthritis with proinflammatory and matrix-degrading activities. Arthritis Rheum 2007,56(9):2829\u20132839.","journal-title":"Arthritis Rheum"},{"issue":"3","key":"554_CR5_554","doi-asserted-by":"publisher","first-page":"1748","DOI":"10.4049\/jimmunol.178.3.1748","volume":"178","author":"AR Moschen","year":"2007","unstructured":"Moschen AR, Kaser A, Enrich B, Mosheimer B, Theurl M, Niederegger H, Tilg H: Visfatin, an adipocytokine with proinflammatory and immunomodulating properties. J Immunol 2007,178(3):1748\u20131758.","journal-title":"J Immunol"},{"issue":"11","key":"554_CR6_554","doi-asserted-by":"publisher","first-page":"3225","DOI":"10.1002\/1521-4141(200211)32:11<3225::AID-IMMU3225>3.0.CO;2-L","volume":"32","author":"A Rongvaux","year":"2002","unstructured":"Rongvaux A, Shea RJ, Mulks MH, Gigot D, Urbain J, Leo O, Andris F: Pre-B-cell colony-enhancing factor, whose expression is up-regulated in activated lymphocytes, is a nicotinamide phosphoribosyltransferase, a cytosolic enzyme involved in NAD biosynthesis. Eur J Immunol 2002,32(11):3225\u20133234.","journal-title":"Eur J Immunol"},{"issue":"5543","key":"554_CR7_554","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1126\/science.294.5543.870","volume":"294","author":"Q Huang","year":"2001","unstructured":"Huang Q, Liu D, Majewski P, Schulte LC, Korn JM, Young RA, Lander ES, Hacohen N: The plasticity of dendritic cell responses to pathogens and their components. Science 2001,294(5543):870\u2013875.","journal-title":"Science"},{"issue":"4","key":"554_CR8_554","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1016\/j.bbrc.2006.02.109","volume":"342","author":"J Iqbal","year":"2006","unstructured":"Iqbal J, Zaidi M: TNF regulates cellular NAD + metabolism in primary macrophages. Biochem Biophys Res Commun 2006,342(4):1312\u20131318.","journal-title":"Biochem Biophys Res Commun"},{"issue":"2","key":"554_CR9_554","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.diabres.2010.03.020","volume":"89","author":"YS Kang","year":"2010","unstructured":"Kang YS, Song HK, Lee MH, Ko GJ, Cha DR: Plasma concentration of visfatin is a new surrogate marker of systemic inflammation in type 2 diabetic patients. Diabetes Res Clin Pract 2010,89(2):141\u2013149.","journal-title":"Diabetes Res Clin Pract"},{"issue":"4","key":"554_CR10_554","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1159\/000276986","volume":"10","author":"P Daniel","year":"2010","unstructured":"Daniel P, Lesniowski B, Mokrowiecka A, Jasinska A, Pietruczuk M, Malecka-Panas E: Circulating levels of visfatin, resistin and pro-inflammatory cytokine interleukin-8 in acute pancreatitis. Pancreatology 2010,10(4):477\u2013482.","journal-title":"Pancreatology"},{"key":"554_CR11_554","volume-title":"Rheumatol Int","author":"Y Duan","year":"2011","unstructured":"Duan Y, Hao D, Li M, Wu Z, Li D, Yang X, Qiu G: Increased synovial fluid visfatin is positively linked to cartilage degradation biomarkers in osteoarthritis. Rheumatol Int 2011."},{"issue":"9","key":"554_CR12_554","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1172\/JCI19930","volume":"113","author":"SH Jia","year":"2004","unstructured":"Jia SH, Li Y, Parodo J, Kapus A, Fan L, Rotstein OD, Marshall JC: Pre-B cell colony-enhancing factor inhibits neutrophil apoptosis in experimental inflammation and clinical sepsis. J Clin Invest 2004,113(9):1318\u20131327.","journal-title":"J Clin Invest"},{"issue":"1","key":"554_CR13_554","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/s11906-007-0007-5","volume":"9","author":"JK Sethi","year":"2007","unstructured":"Sethi JK: Is PBEF\/visfatin\/Nampt an authentic adipokine relevant to the metabolic syndrome? Curr Hypertens Rep 2007,9(1):33\u201338.","journal-title":"Curr Hypertens Rep"},{"issue":"4","key":"554_CR14_554","first-page":"251","volume":"15","author":"D Koczan","year":"2005","unstructured":"Koczan D, Guthke R, Thiesen HJ, Ibrahim SM, Kundt G, Krentz H, Gross G, Kunz M: Gene expression profiling of peripheral blood mononuclear leukocytes from psoriasis patients identifies new immune regulatory molecules. Eur J Dermatol 2005,15(4):251\u2013257.","journal-title":"Eur J Dermatol"},{"issue":"5","key":"554_CR15_554","doi-asserted-by":"publisher","first-page":"e2267","DOI":"10.1371\/journal.pone.0002267","volume":"3","author":"N Busso","year":"2008","unstructured":"Busso N, Karababa M, Nobile M, Rolaz A, Van-Gool F, Galli M, Leo O, So A, De-Smedt T: Pharmacological inhibition of nicotinamide phosphoribosyltransferase\/visfatin enzymatic activity identifies a new inflammatory pathway linked to NAD. PLoS One 2008,3(5):e2267.","journal-title":"PLoS One"},{"issue":"2","key":"554_CR16_554","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1038\/nm.1906","volume":"15","author":"F Van-Gool","year":"2009","unstructured":"Van-Gool F, Galli M, Gueydan C, Kruys V, Prevot PP, Bedalov A, Mostoslavsky R, Alt FW, De-Smedt T, Leo O: Intracellular NAD levels regulate tumor necrosis factor protein synthesis in a sirtuin-dependent manner. Nat Med 2009,15(2):206\u2013210.","journal-title":"Nat Med"},{"issue":"11","key":"554_CR17_554","doi-asserted-by":"publisher","first-page":"e7897","DOI":"10.1371\/journal.pone.0007897","volume":"4","author":"S Bruzzone","year":"2009","unstructured":"Bruzzone S, Fruscione F, Morando S, Ferrando T, Poggi A, Garuti A, D'Urso A, Selmo M, Benvenuto F, Cea M, et al.: Catastrophic NAD + depletion in activated T lymphocytes through Nampt inhibition reduces demyelination and disability in EAE. PLoS One 2009,4(11):e7897.","journal-title":"PLoS One"},{"issue":"5","key":"554_CR18_554","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1097\/01.shk.0000159929.87737.5c","volume":"23","author":"M Maegele","year":"2005","unstructured":"Maegele M, Riess P, Sauerland S, Bouillon B, Hess S, McIntosh TK, Mautes A, Brockmann M, Koebke J, Knifka J, et al.: Characterization of a new rat model of experimental combined neurotrauma. Shock 2005,23(5):476\u2013481.","journal-title":"Shock"},{"issue":"3","key":"554_CR19_554","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/j.nbd.2003.11.015","volume":"15","author":"C Profyris","year":"2004","unstructured":"Profyris C, Cheema SS, Zang D, Azari MF, Boyle K, Petratos S: Degenerative and regenerative mechanisms governing spinal cord injury. Neurobiol Dis 2004,15(3):415\u2013436.","journal-title":"Neurobiol Dis"},{"issue":"3","key":"554_CR20_554","doi-asserted-by":"publisher","first-page":"189","DOI":"10.2174\/157488908786242434","volume":"3","author":"CC Chan","year":"2008","unstructured":"Chan CC: Inflammation: beneficial or detrimental after spinal cord injury? Recent Pat CNS Drug Discov 2008,3(3):189\u2013199.","journal-title":"Recent Pat CNS Drug Discov"},{"issue":"3","key":"554_CR21_554","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1124\/jpet.105.097188","volume":"316","author":"T Genovese","year":"2006","unstructured":"Genovese T, Mazzon E, Crisafulli C, Di-Paola R, Muia C, Bramanti P, Cuzzocrea S: Immunomodulatory effects of etanercept in an experimental model of spinal cord injury. J Pharmacol Exp Ther 2006,316(3):1006\u20131016.","journal-title":"J Pharmacol Exp Ther"},{"issue":"6","key":"554_CR22_554","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1089\/0897715041269641","volume":"21","author":"E Park","year":"2004","unstructured":"Park E, Velumian AA, Fehlings MG: The role of excitotoxicity in secondary mechanisms of spinal cord injury: a review with an emphasis on the implications for white matter degeneration. J Neurotrauma 2004,21(6):754\u2013774.","journal-title":"J Neurotrauma"},{"issue":"2","key":"554_CR23_554","doi-asserted-by":"publisher","first-page":"145","DOI":"10.3171\/spi.2006.4.2.145","volume":"4","author":"T Genovese","year":"2006","unstructured":"Genovese T, Mazzon E, Mariotto S, Menegazzi M, Cardali S, Conti A, Suzuki H, Bramanti P, Cuzzocrea S: Modulation of nitric oxide homeostasis in a mouse model of spinal cord injury. J Neurosurg Spine 2006,4(2):145\u2013153.","journal-title":"J Neurosurg Spine"},{"issue":"7","key":"554_CR24_554","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/S0165-6147(98)01193-6","volume":"19","author":"C Szabo","year":"1998","unstructured":"Szabo C, Dawson VL: Role of poly(ADP-ribose) synthetase in inflammation and ischaemia-reperfusion. Trends Pharmacol Sci 1998,19(7):287\u2013298.","journal-title":"Trends Pharmacol Sci"},{"issue":"9","key":"554_CR25_554","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1089\/neu.2004.21.1255","volume":"21","author":"GS Scott","year":"2004","unstructured":"Scott GS, Szabo C, Hooper DC: Poly(ADP-ribose) polymerase activity contributes to peroxynitrite-induced spinal cord neuronal cell death in vitro. J Neurotrauma 2004,21(9):1255\u20131263.","journal-title":"J Neurotrauma"},{"issue":"1","key":"554_CR26_554","first-page":"38","volume":"10","author":"AS Rivlin","year":"1978","unstructured":"Rivlin AS, Tator CH: Effect of duration of acute spinal cord compression in a new acute cord injury model in the rat. Surgical neurology 1978,10(1):38\u201343.","journal-title":"Surgical neurology"},{"issue":"3","key":"554_CR27_554","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1124\/jpet.111.184630","volume":"338","author":"C Travelli","year":"2011","unstructured":"Travelli C, Drago V, Maldi E, Kaludercic N, Galli U, Boldorini R, Di-Lisa F, Tron GC, Canonico PL, Genazzani AA: Reciprocal potentiation of the antitumoral activities of FK866, an inhibitor of nicotinamide phosphoribosyltransferase, and etoposide or cisplatin in neuroblastoma cells. J Pharmacol Exp Ther 2011,338(3):829\u2013840.","journal-title":"J Pharmacol Exp Ther"},{"issue":"3","key":"554_CR28_554","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/0160-5402(85)90029-4","volume":"14","author":"KM Mullane","year":"1985","unstructured":"Mullane KM, Kraemer R, Smith B: Myeloperoxidase activity as a quantitative assessment of neutrophil infiltration into ischemic myocardium. J Pharmacol Methods 1985,14(3):157\u2013167.","journal-title":"J Pharmacol Methods"},{"issue":"1","key":"554_CR29_554","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0031-6997(24)01484-4","volume":"53","author":"S Cuzzocrea","year":"2001","unstructured":"Cuzzocrea S, Riley DP, Caputi AP, Salvemini D: Antioxidant therapy: a new pharmacological approach in shock, inflammation, and ischemia\/reperfusion injury. Pharmacological reviews 2001,53(1):135\u2013159.","journal-title":"Pharmacological reviews"},{"issue":"6","key":"554_CR30_554","first-page":"1126","volume":"16","author":"TB Shea","year":"1994","unstructured":"Shea TB: Technical report an inexpensive densitometric analysis system using a Macintosh computer and a desktop scanner. BioTechniques 1994,16(6):1126\u20131128.","journal-title":"BioTechniques"},{"issue":"4","key":"554_CR31_554","doi-asserted-by":"publisher","first-page":"279","DOI":"10.2143\/AC.57.4.2005427","volume":"57","author":"BH Sirin","year":"2002","unstructured":"Sirin BH, Ortac R, Cerrahoglu M, Saribulbul O, Baltalarli A, Celebisoy N, Iskesen I, Rendeci O: Ischaemic preconditioning reduces spinal cord injury in transient ischaemia. Acta Cardiol 2002,57(4):279\u2013285.","journal-title":"Acta Cardiol"},{"issue":"9","key":"554_CR32_554","doi-asserted-by":"publisher","first-page":"e12170","DOI":"10.1371\/journal.pone.0012170","volume":"5","author":"E Esposito","year":"2010","unstructured":"Esposito E, Mazzon E, Paterniti I, Impellizzeri D, Bramanti P, Cuzzocrea S: Olprinone attenuates the acute inflammatory response and apoptosis after spinal cord trauma in mice. PLoS One 2010,5(9):e12170.","journal-title":"PLoS One"},{"issue":"9","key":"554_CR33_554","doi-asserted-by":"crossref","first-page":"3251","DOI":"10.1523\/JNEUROSCI.18-09-03251.1998","volume":"18","author":"JR Bethea","year":"1998","unstructured":"Bethea JR, Castro M, Keane RW, Lee TT, Dietrich WD, Yezierski RP: Traumatic spinal cord injury induces nuclear factor-kappaB activation. J Neurosci 1998,18(9):3251\u20133260.","journal-title":"J Neurosci"},{"issue":"5","key":"554_CR34_554","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1089\/neu.2006.23.635","volume":"23","author":"DM Basso","year":"2006","unstructured":"Basso DM, Fisher LC, Anderson AJ, Jakeman LB, McTigue DM, Popovich PG: Basso Mouse Scale for locomotion detects differences in recovery after spinal cord injury in five common mouse strains. J Neurotrauma 2006,23(5):635\u2013659.","journal-title":"J Neurotrauma"},{"issue":"2","key":"554_CR35_554","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1021\/jm9010669","volume":"53","author":"G Colombano","year":"2010","unstructured":"Colombano G, Travelli C, Galli U, Caldarelli A, Chini MG, Canonico PL, Sorba G, Bifulco G, Tron GC, Genazzani AA: A novel potent nicotinamide phosphoribosyltransferase inhibitor synthesized via click chemistry. J Med Chem 2010,53(2):616\u2013623.","journal-title":"J Med Chem"},{"issue":"7","key":"554_CR36_554","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1038\/sj.sc.3101483","volume":"41","author":"ON Hausmann","year":"2003","unstructured":"Hausmann ON: Post-traumatic inflammation following spinal cord injury. Spinal Cord 2003,41(7):369\u2013378.","journal-title":"Spinal Cord"},{"issue":"4","key":"554_CR37_554","doi-asserted-by":"publisher","first-page":"758","DOI":"10.2337\/dc07-1544","volume":"31","author":"R Adya","year":"2008","unstructured":"Adya R, Tan BK, Chen J, Randeva HS: Nuclear factor-kappaB induction by visfatin in human vascular endothelial cells: its role in MMP-2\/9 production and activation. Diabetes Care 2008,31(4):758\u2013760.","journal-title":"Diabetes Care"},{"issue":"11","key":"554_CR38_554","doi-asserted-by":"publisher","first-page":"1759","DOI":"10.1016\/j.bbamcr.2009.09.006","volume":"1793","author":"JY Kim","year":"2009","unstructured":"Kim JY, Bae YH, Bae MK, Kim SR, Park HJ, Wee HJ, Bae SK: Visfatin through STAT3 activation enhances IL-6 expression that promotes endothelial angiogenesis. Biochim Biophys Acta 2009,1793(11):1759\u20131767.","journal-title":"Biochim Biophys Acta"},{"issue":"1","key":"554_CR39_554","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1006\/exnr.1998.6785","volume":"151","author":"SL Carlson","year":"1998","unstructured":"Carlson SL, Parrish ME, Springer JE, Doty K, Dossett L: Acute inflammatory response in spinal cord following impact injury. Exp Neurol 1998,151(1):77\u201388.","journal-title":"Exp Neurol"},{"issue":"Suppl 1","key":"554_CR40_554","first-page":"S83","volume":"9","author":"AR Blight","year":"1992","unstructured":"Blight AR: Macrophages and inflammatory damage in spinal cord injury. J Neurotrauma 1992,9(Suppl 1):S83\u201391.","journal-title":"J Neurotrauma"},{"issue":"1-2","key":"554_CR41_554","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.brainres.2005.10.069","volume":"1066","author":"W Gomes-Leal","year":"2005","unstructured":"Gomes-Leal W, Corkill DJ, Picanco-Diniz CW: Systematic analysis of axonal damage and inflammatory response in different white matter tracts of acutely injured rat spinal cord. Brain Res 2005,1066(1\u20132):57\u201370.","journal-title":"Brain Res"},{"issue":"14","key":"554_CR42_554","doi-asserted-by":"crossref","first-page":"5810","DOI":"10.1523\/JNEUROSCI.19-14-05810.1999","volume":"19","author":"SJ Davies","year":"1999","unstructured":"Davies SJ, Goucher DR, Doller C, Silver J: Robust regeneration of adult sensory axons in degenerating white matter of the adult rat spinal cord. J Neurosci 1999,19(14):5810\u20135822.","journal-title":"J Neurosci"},{"issue":"5","key":"554_CR43_554","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1007\/s004010051112","volume":"98","author":"GL Li","year":"1999","unstructured":"Li GL, Farooque M, Holtz A, Olsson Y: Apoptosis of oligodendrocytes occurs for long distances away from the primary injury after compression trauma to rat spinal cord. Acta Neuropathol 1999,98(5):473\u2013480.","journal-title":"Acta Neuropathol"},{"issue":"2","key":"554_CR44_554","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/S0306-4522(00)00173-1","volume":"99","author":"M Li","year":"2000","unstructured":"Li M, Ona VO, Chen M, Kaul M, Tenneti L, Zhang X, Stieg PE, Lipton SA, Friedlander RM: Functional role and therapeutic implications of neuronal caspase-1 and -3 in a mouse model of traumatic spinal cord injury. Neuroscience 2000,99(2):333\u2013342.","journal-title":"Neuroscience"},{"issue":"1-2","key":"554_CR45_554","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/S0169-328X(02)00558-2","volume":"109","author":"A Chiarugi","year":"2002","unstructured":"Chiarugi A: Characterization of the molecular events following impairment of NF-kappaB-driven transcription in neurons. Brain Res Mol Brain Res 2002,109(1\u20132):179\u2013188.","journal-title":"Brain Res Mol Brain Res"},{"issue":"12","key":"554_CR46_554","doi-asserted-by":"publisher","first-page":"2216","DOI":"10.1111\/j.1460-9568.2011.07714.x","volume":"33","author":"SE Nasrabady","year":"2011","unstructured":"Nasrabady SE, Kuzhandaivel A, Nistri A: Studies of locomotor network neuroprotection by the selective poly(ADP-ribose) polymerase-1 inhibitor PJ-34 against excitotoxic injury to the rat spinal cord in vitro. Eur J Neurosci 2011,33(12):2216\u20132227.","journal-title":"Eur J Neurosci"},{"issue":"12","key":"554_CR47_554","doi-asserted-by":"publisher","first-page":"e4090","DOI":"10.1371\/journal.pone.0004090","volume":"3","author":"JA Pfister","year":"2008","unstructured":"Pfister JA, Ma C, Morrison BE, D'Mello SR: Opposing effects of sirtuins on neuronal survival: SIRT1-mediated neuroprotection is independent of its deacetylase activity. PLoS One 2008,3(12):e4090.","journal-title":"PLoS One"},{"issue":"5837","key":"554_CR48_554","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1126\/science.1143780","volume":"317","author":"TF Outeiro","year":"2007","unstructured":"Outeiro TF, Kontopoulos E, Altmann SM, Kufareva I, Strathearn KE, Amore AM, Volk CB, Maxwell MM, Rochet JC, McLean PJ, et al.: Sirtuin 2 inhibitors rescue alpha-synuclein-mediated toxicity in models of Parkinson's disease. Science 2007,317(5837):516\u2013519.","journal-title":"Science"}],"container-title":["Journal of Neuroinflammation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1742-2094-9-66.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/1742-2094-9-66\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1742-2094-9-66","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1742-2094-9-66.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,25]],"date-time":"2025-03-25T18:23:45Z","timestamp":1742927025000},"score":1,"resource":{"primary":{"URL":"https:\/\/jneuroinflammation.biomedcentral.com\/articles\/10.1186\/1742-2094-9-66"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,4,10]]},"references-count":48,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["554"],"URL":"https:\/\/doi.org\/10.1186\/1742-2094-9-66","relation":{},"ISSN":["1742-2094"],"issn-type":[{"value":"1742-2094","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,4,10]]},"assertion":[{"value":"9 January 2012","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 April 2012","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 April 2012","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"66"}}